Ocugen (OCGN) Times Interest Earned (2014 - 2026)
Ocugen (OCGN) reported Times Interest Earned of -$13.51 for Q1 2026, down 17.15% on a YoY basis from -$16.31 in Q1 2025, and down 5.92% quarter-over-quarter from -$12.76 in Q4 2025.
Ocugen (OCGN) Times Interest Earned (2014 - 2026) Analysis & Trends
Ocugen has reported Times Interest Earned for 10 years, with the latest figure at -$13.51 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 17.15% year-over-year to -$13.51; the trailing twelve-month figure through Mar 2026 stood at -$16.71 (up 44.74% YoY), and the FY2025 full-year result was -$12.13, up 84.76% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$13.51, down from -$12.76 in the prior quarter.
- The five-year high for Times Interest Earned was -$11.54 in Q1 2025, with the low at -$456.97 in Q3 2024.
- Historically, Times Interest Earned has averaged -$88.54 across 3 years, with a median of -$13.46 in 2025.
- Annual changes were most pronounced in 2025 — Times Interest Earned soared 97.06% — and 2026, when it fell 17.15%.
- Ocugen's Times Interest Earned stood at -$23.03 in 2024, then surged by 44.59% to -$12.76 in 2025, then declined by 5.92% to -$13.51 in 2026.
- The last three Times Interest Earned figures came in at -$13.51 (Q1 2026), -$12.76 (Q4 2025), and -$13.41 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -13.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.51 |
| Dec 31, 2025 | -12.76 |
| Sep 30, 2025 | -13.41 |
| Mar 31, 2025 | -11.54 |
| Dec 31, 2024 | -23.03 |
| Sep 30, 2024 | -456.97 |
| Dec 31, 2021 | -728.60 |
| Sep 30, 2021 | -567.84 |
| Jun 30, 2021 | -1,280.50 |
| Mar 31, 2021 | -352.85 |
| Dec 31, 2020 | -22.94 |
| Sep 30, 2020 | -34.87 |
| Jun 30, 2020 | -13.57 |
| Mar 31, 2020 | -261.93 |
| Dec 31, 2019 | -288.62 |
| Sep 30, 2019 | -3.41 |
| Jun 30, 2019 | -8.90 |
| Mar 31, 2019 | -6.96 |
| Dec 31, 2018 | -7.95 |
| Sep 30, 2018 | -2.40 |